Navigation Links
New details on microtubules and how the anti-cancer drug Taxol works
Date:5/22/2014

45;-tubulin that is buried, and an "E-site" on the β-tubulin that is exposed when the tubulin is depolymerized. Previous microtubule reconstruction studies were unable to distinguish the highly similar α-tubulin and β-tubulin from each other.

"To be able to distinguish the α-tubulin from the β-tubulin, we had to resolve our images at better than 8 , which most prior cryo-EM studies were unable to do," Nogales says. "For that, we marked the subunits with kinesin, a protein motor that distinguishes between α- and β-tubulin."

Nogales and her colleagues found that GTP hydrolysis and the release of the phosphate (GTP becomes GDP) leads to a compaction of the E-site and a rearrangement of the α-tubulin monomer that generates a strain on the microtubule that destabilizes its structure. Taxol binding leads to a reversal of this E-site compaction and α-tubulin rearrangement that restores structural stabilization.

"Remarkably, Taxol binding globally reverses the majority of the conformational changes we observe when comparing the GMPCPP and GDP states," Nogales says. "We propose that GTP hydrolysis leads to conformational strain in the microtubule that would be released by bending during depolymerization. This model is consistent with the changes we observe upon taxol binding, which dramatically stabilizes the microtubule lattice. Our analysis supports a model in which microtubule-stabilizing agents like Taxol modulate conformational strain and longitudinal contacts in the microtubule lattice."


'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Scientists uncover startlingly new functional details of common anti-diabetic drugs
2. Report details multiple commercial uses of wireless sensor networks
3. Quantum effects help cells capture light, but the details are obscure
4. Wonder of Nanotechnology details research enabling nanoscale optoelectronic devices
5. Demand for details on food labels includes the good -- and the bad
6. Study details paired risk factors in preeclampsia
7. Biologists uncover details of how we squelch defective neurons
8. Scientists discover new details about rice blast, a deadly plant fungus
9. Prehistoric ghosts revealing new details
10. New book details the biological and cultural diversity of Khawa Karpo, sacred mountain of Tibet
11. Study details essential role of trust in agricultural biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New details on microtubules and how the anti-cancer drug Taxol works
(Date:5/20/2015)... DUBLIN , May 20, 2015 ... Markets ( http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the ... of the Global Iris Recognition Market" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service analyses ... across the government and commercial sectors, ...
(Date:5/19/2015)... NEW YORK , May 19, 2015  Technology ... resources both internally and in the cloud. Passwords and ... the use of OTP and standards-based specifications such as ... that the outmoded use of passwords presents for BYOD, ... needs a unified biometric identity protocol. ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... emotional expression that is innate in human beings. This means ... phenomenon. However, the fear of being laughed at causes some ... as gelotophobia, a disorder that affects people in all cultures ... and another who suffers from gelotophobia? One of the aims ...
... DIEGO, Oct. 13 CareFusion Corporation (NYSE: CFN ), ... launch of the EnVe(TM) ventilator - a high-performance critical care ... the EnVe ventilator is 70-80 pounds lighter than other intensive ... technology to help hospitals increase the quality of patient care ...
... useful in electronics applications, Kansas State University engineers made ... Vikas Berry is a K-State assistant professor of chemical ... a single atom thick and discovered just five years ... its electronics properties -- Berry and Kabeer Jasuja, a ...
Cached Biology News:Fear of being laughed at crosses cultural boundaries 2Fear of being laughed at crosses cultural boundaries 3Fear of being laughed at crosses cultural boundaries 4CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator 2CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator 324-carat gold 'snowflakes' improve graphene's electrical properties 2
(Date:5/28/2015)... 28, 2015 ... announced the addition of Jain PharmaBiotech,s ... Markets and Companies"  to their offering.  ... describes and evaluates animal biotechnology and ... pharmaceuticals as well as improvement in ...
(Date:5/28/2015)... May 27, 2015 Research and Markets( ... PharmaBiotech,s new report "Neuroprotection - Drugs, Markets ... This report describes the role of neuroprotection in ... the nervous system as well as in chronic ... the underlying mechanisms of damage to neural tissues ...
(Date:5/28/2015)... McKinney, Texas (PRWEB) May 28, 2015 ... products for use in applications such as animal ... fat and oil reduction in wastewater treatment plants ... be attending the World Pork Expo, June 3-5 ... earlier this year in a Wall Street Journal ...
(Date:5/28/2015)... , May 28, 2015 Biscayne Pharmaceuticals, ... potential of its growth hormone-releasing hormone (GHRH) technology will ... 2015 ASCO Annual Meeting. The data show that the ... anti-cancer GHRH blockers, is present on many primary breast ... suggest that GHRH antagonists could have broad anti-cancer potential ...
Breaking Biology Technology:Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 3Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 3DryLet to Showcase Patented ManureMagicâ„¢ at the 2015 World Pork Expo, June 3-5 in Des Moines, Iowa 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 3
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) has completed ... its U.K. clinical trial to evaluate the,anti-tumour ... with docetaxel (Taxotere(R)) in patients with advanced ... The,principal investigator is Professor Hardev Pandha of ...
... (Amex:,SVA), a vaccine-focused biotech company in China, announced today ... on Thursday, September 4,2008 at 9:00 a.m. Beijing Time. ... Xi Road, Haidian District, Beijing, PRC and at No. ... as of August 1,2008 will be eligible to vote ...
... today announced that the first patient has received an ... Company,s first oncology product, MM-121, a,fully human monoclonal antibody ... ErbB3 receptor., ErbB3 is a receptor in the ... cancer signaling. With the initiation of the Phase 1 ...
Cached Biology Technology:Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial 2Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial 3Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist 3
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
IHC detection kit for PCNA in cells and tissues...
Request Info...
... Immunogen: Synthetic peptide derived from ... WNT1 protein. Specificity: Reacts with ... Reactivity: Human Mouse (positive controls: ... cell lysates and mouse Mouse-1 cell ...
Biology Products: